产品描述: | Tipiracil (hydrochloride) is a thymidine phosphorylase inhibitor (TPI), used for cancer research |
靶点: |
Nucleoside Antimetabolite/Analog;NucleosideAntimetabolite/Analog |
体外研究: |
Tipiracil has antiangiogenic effect, and inhibits proliferation of endothelial cells. Tipiracil is a potent inhibitor of thymidine phosphorylase, which is the enzyme that degrades FTD |
参考文献: |
1. Peters GJ, et al. TAS-102: more than an antimetabolite. Lancet Oncol. 2012 Dec;13(12):e518-9. 2. Yoshino T, et al. TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial. Lancet Oncol. 2012 Oct;13(10):993-1001. |
溶解性: |
Soluble in H2O |
保存条件: |
-20℃ |
配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
1 mM |
3.583 ml |
17.913 ml |
35.826 ml |
5 mM |
0.717 ml |
3.583 ml |
7.165 ml |
10 mM |
0.358 ml |
1.791 ml |
3.583 ml |
50 mM |
0.072 ml |
0.358 ml |
0.717 ml |
|
注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |